Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C36H61NO28 |
| Molecular Weight | 955.8594 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 26 / 26 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]5(O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](OC)[C@@H]2O)O[C@H](CO)[C@H]1O[C@]3([H])O[C@H](CO)[C@H](O)[C@H](O[C@@]4(C[C@H](O)[C@@H](NC(C)=O)[C@@]([H])(O4)[C@@H](O)[C@H](O)CO)C(O)=O)[C@H]3O)O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]5O
InChI
InChIKey=OJVWCHCGJALQIL-BADDBONTSA-N
InChI=1S/C36H61NO28/c1-9-17(45)21(49)22(50)32(57-9)63-30-25(53)34(62-28-19(47)13(6-39)58-31(56-3)23(28)51)60-15(8-41)26(30)61-33-24(52)29(20(48)14(7-40)59-33)65-36(35(54)55)4-11(43)16(37-10(2)42)27(64-36)18(46)12(44)5-38/h9,11-34,38-41,43-53H,4-8H2,1-3H3,(H,37,42)(H,54,55)/t9-,11-,12+,13+,14+,15+,16+,17+,18-,19-,20-,21+,22-,23+,24+,25+,26+,27+,28-,29-,30+,31+,32-,33-,34-,36-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
77693
Created by
admin on Sat Dec 16 13:06:11 UTC 2023 , Edited by admin on Sat Dec 16 13:06:11 UTC 2023
|
||
|
FDA ORPHAN DRUG |
106297
Created by
admin on Sat Dec 16 13:06:11 UTC 2023 , Edited by admin on Sat Dec 16 13:06:11 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
WLZ3BA9R26
Created by
admin on Sat Dec 16 13:06:11 UTC 2023 , Edited by admin on Sat Dec 16 13:06:11 UTC 2023
|
PRIMARY | |||
|
168678-84-0
Created by
admin on Sat Dec 16 13:06:11 UTC 2023 , Edited by admin on Sat Dec 16 13:06:11 UTC 2023
|
PRIMARY | |||
|
162623684
Created by
admin on Sat Dec 16 13:06:11 UTC 2023 , Edited by admin on Sat Dec 16 13:06:11 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
